Among 106 patients screening by DRE, there were 53 prostate cancer patients (50%), 50 BPH patients (47.17%), 2 high grade PIN (1.88%) and 1 prostatitis patient (0.95%). Conclusions: Prostate biopsy under TRUS guide is valuable.